Total Payments
$5,162
2023 Payments
$36.06
Companies
27
Transactions
305
Medicare Patients
757
Medicare Billing
$97,667
Payment Breakdown by Category
Food & Beverage$5,149 (99.8%)
Education$12.70 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,149 | 304 | 99.8% |
| Education | $12.70 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $794.35 | 42 | $0 (2022) |
| PFIZER INC. | $514.24 | 31 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $484.12 | 38 | $0 (2020) |
| Astellas Pharma US Inc | $368.87 | 23 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $322.78 | 21 | $0 (2022) |
| CSL Behring | $315.00 | 21 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $314.79 | 20 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $302.72 | 20 | $0 (2020) |
| Allergan Inc. | $251.81 | 11 | $0 (2018) |
| Relypsa, Inc. | $250.81 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $36.06 | 2 | AstraZeneca Pharmaceuticals LP ($19.00) |
| 2022 | $423.67 | 21 | E.R. Squibb & Sons, L.L.C. ($124.79) |
| 2021 | $41.41 | 2 | Astellas Pharma US Inc ($21.68) |
| 2020 | $270.93 | 16 | Janssen Pharmaceuticals, Inc ($69.26) |
| 2019 | $1,261 | 75 | Janssen Pharmaceuticals, Inc ($245.47) |
| 2018 | $1,447 | 89 | Janssen Pharmaceuticals, Inc ($217.50) |
| 2017 | $1,682 | 100 | Janssen Pharmaceuticals, Inc ($196.03) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 2 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/06/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/05/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/28/2020 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/25/2020 | Astellas Pharma US Inc | CRESEMBA (Drug), MYCAMINE, LEXISCAN | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 02/24/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/14/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/10/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2020 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/17/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/15/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/12/2019 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/06/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 152 | 268 | $69,107 | $24,345 |
| 2022 | 5 | 108 | 142 | $25,771 | $11,266 |
| 2021 | 6 | 252 | 358 | $60,030 | $30,897 |
| 2020 | 6 | 245 | 296 | $61,130 | $31,159 |
Total Patients
757
Total Services
1,064
Medicare Billing
$97,667
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 159 | $37,688 | $14,472 | 38.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $14,404 | $3,992 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 39 | $9,574 | $3,410 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 25 | $4,636 | $1,537 | 33.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $2,805 | $934.00 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 73 | $8,537 | $3,922 | 45.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $7,627 | $3,438 | 45.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $5,136 | $2,050 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 13 | $2,295 | $1,102 | 48.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 15 | $2,175 | $754.42 | 34.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 94 | 187 | $21,505 | $11,079 | 51.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 51 | $16,065 | $9,003 | 56.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 44 | $7,040 | $3,738 | 53.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 16 | 16 | $5,040 | $2,370 | 47.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 39 | 39 | $5,655 | $2,363 | 41.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $4,725 | $2,344 | 49.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 90 | 90 | $28,350 | $14,979 | 52.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 61 | 99 | $11,385 | $5,679 | 49.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 44 | $7,040 | $3,559 | 50.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 18 | 18 | $5,670 | $2,939 | 51.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 27 | $6,075 | $2,900 | 47.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 17 | 18 | $2,610 | $1,103 | 42.3% |
About Dr. Slade Hodges, M.D
Dr. Slade Hodges, M.D is a Hospitalist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1073756888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Slade Hodges, M.D has received a total of $5,162 in payments from pharmaceutical and medical device companies, with $36.06 received in 2023. These payments were reported across 305 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,149).
As a Medicare-enrolled provider, Hodges has provided services to 757 Medicare beneficiaries, totaling 1,064 services with total Medicare billing of $97,667. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Dallas, TX
- Active Since 04/08/2009
- Last Updated 05/02/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1073756888
Products in Payments
- XARELTO (Drug) $794.35
- ELIQUIS (Drug) $592.19
- Kcentra (Biological) $315.00
- ENTRESTO (Drug) $302.72
- Veltassa (Drug) $288.03
- CRESEMBA (Drug) $262.73
- LOKELMA (Drug) $238.67
- XIFAXAN (Drug) $222.35
- CHANTIX (Drug) $214.81
- DIFICID (Drug) $209.25
- ZERBAXA (Drug) $202.53
- LANTUS (Drug) $153.69
- JARDIANCE (Drug) $138.36
- AVYCAZ (Drug) $138.06
- PRADAXA (Drug) $130.54
- TEFLARO (Drug) $113.75
- BROVANA (Drug) $91.49
- SAMSCA (Drug) $77.37
- BEVYXXA (Drug) $72.08
- Caldolor (Drug) $62.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Dallas
Dr. Ali Bagheri, Md, MD
Hospitalist — Payments: $11,446
Hospitalist $11,446
Janae' Richard
Hospitalist — Payments: $9,928
Hospitalist $9,928
Dr. Anita Khetan, M.d, M.D
Hospitalist — Payments: $9,685
Hospitalist $9,685
Rainer Khetan, M.d, M.D
Hospitalist — Payments: $8,606
Hospitalist $8,606
Dr. Radha Yalamanchili, Md, MD
Hospitalist — Payments: $6,937
Hospitalist $6,937
Amy Gates, Md, MD
Hospitalist — Payments: $6,891
Hospitalist $6,891